Imaging News

Healio and Cardiology Today have compiled the top cardiology headlines of May 2023.

In statin-treated patients with CAD and elevated triglycerides, icosapent ethyl benefited coronary physiology as assessed by CT-derived fractional flow reserve compared with placebo, according to new data from the EVAPORATE trial.

Data show CV risk discrimination improved when adding a coronary artery calcium score to a CHD prediction model based on traditional risk factors; however, there were no changes when adding a polygenic risk score.

Adults with a coronary artery calcium score greater than 300 are at an equivalent risk for major CV events as treated patients with established atherosclerotic CVD, supporting the use of high-dose statins in this population, data show.

In patients with an implantable cardioverter defibrillator, those who had transvenous leads had worse outcomes related to tricuspid regurgitation than those who had subcutaneous leads, according to new data from the ATLAS trial.

A virtual PCI road mapping tool could increase procedural safety vs. conventional angiography by reducing contrast volume and the number of angiograms necessary, a speaker reported.

In patients with angina with nonobstructive CAD, invasive testing increased the likelihood of an angina endotype diagnosis and improved treatment satisfaction compared with controls, but did not improve angina burden, researchers reported.

A drug-eluting coronary implant adaptable to vessel physiology with uncaging elements was safe and effective compared with a contemporary drug-eluting stent, demonstrating superior restoration of vessel motion and function, data show.

Comparing clinical outcomes between intravascular imaging-guided vs. angiography-guided PCI in complex lesions.

Assessing a novel, stick-on thoracic fluid monitor (Microcor, Zoll Medical) for HF management.